军事知识服务平台
整合组学分析在骨肉瘤生物标志物筛选中的应用
Application of an integrated omics analysis for the discovery of biomarkers for osteosarcoma
摘要 目的 建立整合组学分析方法以筛选骨肉瘤早期诊断的生物标志分子.方法 分别采用基因芯片和SELDI-TOF-MS技术筛选候选的骨肉瘤标志基因和骨肉瘤血清标志物.运用Link-test统计学方法对基因芯片和SELDI-TOF-MS数据进行整合分析,提取骨肉瘤早期诊断的候选标志分子.结果 基因芯片在骨肉瘤细胞系中筛选到653个候选骨肉瘤标志基因;SELDI-TOF-MS技术在骨肉瘤患者血清中检测到6个差异显著的候选质谱峰标志物.利用Link-test整合分析一共鉴定出13个候选的骨肉瘤标志分子.结论 整合组学分析法是一个稳定有效的筛选骨肉瘤早期诊断标志分子的方法,可以作为骨肉瘤早期诊断的监测平台.
Abstract:
Objective To apply an integrated omics analysis so as to discover potential biomarkers for an early diagnosis of osteosarcoma.Methods Gene chip and surface-enhanced laser desorption/ionization-time of flight-mass spectra (SELDI-TOF-MS) were employed to screen the marker genes and serum markers of osteosarcoma respectively.The associations of potential biomarkers from the SELDI data and microarray analysis were further inferred by Link-test to identify stable and specific diagnostic biomarkers.Results A total of 653 pre-biomarkers were found in osteosarcoma cells.And six differentially expressed protein peaks with strong statistical significances were detected by SELDI-TOF-MS in the patient's serum samples.Thirteen potential biomarkers for an early diagnosis of osteosarcoma were screened by Linktest.Conclusion As an effective method of identifying osteosarcoma biomarkers,the integrated omics analysis may serve as a monitoring platform for an early diagnosis of osteosarcoma.
Author: LI Guo-dong CAI Zheng-dong MA Xiao-jun SUN Meng-xiong LI Jian
作者单位: 同济大学附属第十人民医院骨科, 上海,200072
刊 名 中华医学杂志 ISTICPKU
年,卷(期): 2012, 92(3)
分类号: R4
机标分类号: R735.2 R576 R979.1
在线出版日期: 2012年3月20日
基金项目: 30170955:国家自然科学基金2010163:上海市卫生局基础科研项目2010kj014:同济大学优秀青年课题项目,